16:11 EDT Tenaya Therapeutics (TNYA) files $300M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNYA:
- Tenaya Therapeutics: Strong Financial Position and Promising Clinical Trial Results Justify Buy Rating
- Biotech Alert: Searches spiking for these stocks today
- Promising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction
- Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
- Buy Rating for Tenaya Therapeutics: Strong Clinical Progress and Financial Stability
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue